Group 1 - Guangji Pharmaceutical's stock price increased by 5.01% on January 27, reaching 8.18 yuan per share, with a trading volume of 235 million yuan and a turnover rate of 8.98%, resulting in a total market capitalization of 2.836 billion yuan [1] - The stock has risen for three consecutive days, with a cumulative increase of 4.7% during this period [1] - Guangji Pharmaceutical, established on May 28, 1993, and listed on November 12, 1999, is based in Wuhan, Hubei Province, and primarily engages in the production and sale of pharmaceutical raw materials, veterinary raw materials, feed additives, and fine chemical products [1] Group 2 - The top ten circulating shareholders of Guangji Pharmaceutical include a fund from Huaxia Fund, specifically the Huaxia CSI 500 Index Enhanced A (007994), which newly entered the top ten shareholders in the third quarter, holding 2.2814 million shares, accounting for 0.66% of circulating shares [2] - The fund has generated an estimated floating profit of approximately 889,800 yuan today and 798,500 yuan during the three-day increase [2] - The Huaxia CSI 500 Index Enhanced A fund was established on March 25, 2020, with a latest scale of 3.37 billion yuan, and has achieved a year-to-date return of 10.75% and a one-year return of 48.88% [2]

Group 1 - The core viewpoint of the news is that HeDa Technology has experienced a significant stock price increase, rising 3.36% to 15.09 CNY per share, with a total market capitalization of 1.628 billion CNY and a cumulative increase of 12.95% over the past five days [1] - HeDa Technology, established on October 11, 2000, and listed on July 27, 2021, specializes in providing comprehensive solutions for the informatization of the water industry, utilizing IoT, big data, and edge computing technologies [1] - The company's revenue composition includes: 53.65% from smart sensing terminals, 30.38% from overall solutions, 9.28% from water management systems, and 6.69% from technical services [1] Group 2 - From the perspective of HeDa Technology's top circulating shareholders, Huaxia Fund's Huaxia CSI 500 Index Enhanced A (007994) has entered the top ten circulating shareholders, holding 1.4909 million shares, which is 1.39% of the circulating shares [2] - The fund has generated a floating profit of approximately 730,500 CNY today and a total of 2,579,300 CNY during the five-day increase [2] - The fund manager, Sun Meng, has a total asset scale of 16.118 billion CNY, with a best fund return of 153.44% and a worst fund return of 21.12% during his tenure [2]

Company Overview - Zhongneng Electric Co., Ltd. is located in Fuzhou, Fujian Province, established on December 2, 2002, and listed on March 19, 2010. The company specializes in the development, manufacturing, and sales of power cable distribution systems related to voltage levels of 35kV and below [1] - The main business revenue composition includes: 87.99% from smart grid products, 8.41% from power construction services, 2.18% from photovoltaic power generation services, and 1.42% from other supplementary services [1] Stock Performance - On January 13, Zhongneng Electric's stock fell by 5.05%, trading at 8.84 CNY per share, with a transaction volume of 496 million CNY and a turnover rate of 12.01%. The total market capitalization is 5.569 billion CNY [1] Shareholder Information - Among the top ten circulating shareholders of Zhongneng Electric, one fund from Huaxia Fund, Huaxia CSI 500 Index Enhanced A (007994), has recently entered the list, holding 2.7408 million shares, which accounts for 0.71% of the circulating shares. The estimated floating loss today is approximately 1.2882 million CNY [2] - Huaxia CSI 500 Index Enhanced A (007994) was established on March 25, 2020, with a current scale of 3.308 billion CNY. Year-to-date returns are 6.48%, ranking 2307 out of 5517 in its category; the one-year return is 48.77%, ranking 1720 out of 4203; and since inception, the return is 157.8% [2]

Group 1 - The core point of the news is that Guangji Pharmaceutical's stock price increased by 5.22% to 9.87 CNY per share, with a trading volume of 635 million CNY and a turnover rate of 20.39%, resulting in a total market capitalization of 3.422 billion CNY [1] - Guangji Pharmaceutical, established on May 28, 1993, and listed on November 12, 1999, is located in Wuxue City, Hubei Province. The company specializes in the production and sales of pharmaceutical raw materials, veterinary raw materials, feed additives, and fine chemical products [1] - The revenue composition of Guangji Pharmaceutical includes 74.56% from raw material products, 22.97% from formulation products, 1.45% from other products, and 1.02% from supplementary sources [1] Group 2 - Among the top ten circulating shareholders of Guangji Pharmaceutical, one fund from Huaxia Fund, the Huaxia CSI 500 Index Enhanced A (007994), has recently entered the list, holding 2.2814 million shares, which accounts for 0.66% of the circulating shares [2] - The Huaxia CSI 500 Index Enhanced A fund was established on March 25, 2020, with a latest scale of 3.308 billion CNY. It has achieved a year-to-date return of 24.47%, ranking 1946 out of 4207 in its category, and a one-year return of 24.63%, ranking 1851 out of 4009 [2] - The fund manager of Huaxia CSI 500 Index Enhanced A is Sun Meng, who has been in the position for 5 years and 261 days, managing a total fund size of 16.118 billion CNY. During his tenure, the best fund return was 131.64%, while the worst was 20.71% [3]

Company Overview - Zhongneng Electric Co., Ltd. is located in Fuzhou, Fujian Province, established on December 2, 2002, and listed on March 19, 2010. The company specializes in the development, manufacturing, and sales of power cable distribution systems related to voltage levels of 35kV and below [1]. Business Segmentation - The main revenue composition of Zhongneng Electric includes: - Smart grid products: 87.99% - Power construction services: 8.41% - Photovoltaic power generation services: 2.18% - Other (supplementary): 1.42% [1]. Stock Performance - On November 17, Zhongneng Electric's stock fell by 5.08%, trading at 11.02 CNY per share, with a transaction volume of 759 million CNY and a turnover rate of 17.25%. The total market capitalization is 6.145 billion CNY [1]. Shareholder Information - Among the top ten circulating shareholders of Zhongneng Electric, one fund from Huaxia Fund, Huaxia CSI 500 Index Enhanced A (007994), has recently entered the list, holding 2.7408 million shares, which accounts for 0.71% of the circulating shares. The estimated floating loss today is approximately 1.617 million CNY [2]. Fund Performance - Huaxia CSI 500 Index Enhanced A (007994) was established on March 25, 2020, with a latest scale of 3.308 billion CNY. Year-to-date return is 27.86%, ranking 1877 out of 4216 in its category; the one-year return is 24.62%, ranking 1679 out of 3956; and since inception, the return is 135.91% [2]. Fund Management - The fund manager of Huaxia CSI 500 Index Enhanced A is Sun Meng, who has been in the position for 5 years and 247 days. The total asset size of the fund is 16.118 billion CNY, with the best fund return during the tenure being 136.83% and the worst being 22.53% [3].

Group 1 - The core point of the news is that Zhongneng Electric experienced a stock price increase of 5.22%, reaching 11.49 CNY per share, with a trading volume of 1.119 billion CNY and a turnover rate of 26.92%, resulting in a total market capitalization of 6.407 billion CNY [1] - Zhongneng Electric, established on December 2, 2002, and listed on March 19, 2010, is located in Fuzhou, Fujian Province. The company specializes in the development, manufacturing, and sales of power cable distribution systems related to voltage levels of 35kV and below [1] - The main revenue composition of Zhongneng Electric includes: 87.99% from smart grid products, 8.41% from power construction services, 2.18% from photovoltaic power generation services, and 1.42% from other supplementary services [1] Group 2 - Among the top ten circulating shareholders of Zhongneng Electric, a fund under Huaxia Fund, specifically Huaxia CSI 500 Index Enhanced A (007994), has newly entered the list in the third quarter, holding 2.7408 million shares, which accounts for 0.71% of the circulating shares [2] - The estimated floating profit for Huaxia CSI 500 Index Enhanced A (007994) today is approximately 1.5622 million CNY [2] - The fund was established on March 25, 2020, with a latest scale of 3.308 billion CNY. Year-to-date returns are 29.16%, ranking 1951 out of 4216 in its category, while the one-year return is 23.07%, ranking 1722 out of 3955 [2]

Group 1 - XinYuan Intelligent Manufacturing (600615.SH) released its Q3 2025 report on October 31, 2025, indicating that three institutional investors disclosed holdings in the company, totaling 77.66 million shares, which accounts for 34.42% of the total share capital [1] - The institutional investors include Dongfang Xinyuan Group Co., Ltd., Chongqing International Trust Co., Ltd. - Xingguo No. 1 Collective Fund Trust Plan, and Chongqing International Trust Co., Ltd. - Hongrui No. 1 Collective Fund Trust Plan, with a combined holding ratio of 34.42% [1] - Compared to the previous quarter, the total institutional holding ratio decreased by 3.65 percentage points [1] Group 2 - In the public fund sector, 45 public funds were disclosed this period, including Jin Ying Hengrun Bond Initiation A, Nuoan Multi-Strategy Mixed A, and others [1]

Group 1 - The core point of the news is that Shanshi Network Technology (688030.SH) reported its Q3 2025 results, revealing significant institutional investor activity with 11 institutions holding a total of 75.54 million shares, representing 41.91% of the total share capital [1] - Among the top ten institutional investors, the combined holding ratio decreased by 3.11 percentage points compared to the previous quarter, indicating a potential shift in investor sentiment [1] - The top ten institutional investors include notable firms such as Shenzhou Cloud Technology, 360 Digital Security Group, and Yixing Guangkong Investment, collectively holding 41.90% of the shares [1] Group 2 - In the public fund sector, two funds increased their holdings compared to the previous period, with a total increase of 0.10% [2] - Two new public funds disclosed their holdings this quarter, including GF SSE Sci-Tech Innovation Board 100 Enhanced Strategy ETF and CITIC Securities CSI 1000 Enhanced A [2] - A total of 80 public funds did not disclose their holdings this quarter, including several notable funds such as Huaxia CSI 500 Enhanced A and Morgan Stanley Multi-Factor Strategy Mixed Fund [2]

Core Insights - The report indicates that as of October 29, 2025, institutional investors hold a total of 117 million shares of Weisaibo (688718.SH), representing 67.06% of the company's total equity, with a slight decrease of 0.69 percentage points from the previous quarter [1] Institutional Holdings - Three institutional investors disclosed their holdings in Weisaibo, including Weisaibo Environmental Materials Holdings Limited, Shanghai Huajia Enterprise Management Partnership (Limited Partnership), and Shanghai Jingri Enterprise Management Partnership (Limited Partnership) [1] - The total institutional holding percentage has decreased by 0.69 percentage points compared to the last quarter [1] Public Fund Activity - A total of 54 public funds were not disclosed in this period compared to the previous quarter, including notable funds such as Huaxia CSI 500 Index Enhanced A, Guotai SSE STAR Market Comprehensive ETF, and Huaxia Smart Vanguard Stock (LOF) A [1] Foreign Investment - One new foreign institutional investor disclosed its holdings this quarter, which is Weisaibo Environmental Materials Holdings Limited [1] - The same foreign institutional investor was not disclosed in the previous quarter [1]

Core Viewpoint - Xinguang Pharmaceutical (300519.SZ) reported its Q3 2025 results, highlighting a decrease in institutional investor holdings and a stable presence of public funds and foreign investments [1] Institutional Holdings - As of October 27, 2025, three institutional investors disclosed holdings in Xinguang Pharmaceutical, totaling 26.0257 million shares, which represents 16.27% of the company's total equity [1] - The institutional holding percentage decreased by 2.47 percentage points compared to the previous quarter [1] Public Fund Activity - In this reporting period, 52 public funds were disclosed, including notable funds such as Jinyuan Shun'an Yuanqi Flexible Allocation Mixed Fund and Huaxia CSI 500 Index Enhanced A [1] Social Security Fund - One new social security fund was disclosed, specifically the招商基金管理有限公司-社保基金1903组合 [1] Foreign Investment - One new foreign institution disclosed holdings, namely 中信证券资产管理(香港)有限公司-客户资金-人民币资金汇入, while BARCLAYS BANK PLC was not disclosed in this period [1]